Efficacy of myo‐inositol and zinc on insulin resistance in a paediatric population with obesity
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.16185 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Valentina Antoniotti und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy. Hauptthemen laut MEDLINE: Inositol, Insulin Resistance, Pediatric Obesity, Zinc. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Cariplo Foundation Grant, University of Piemonte Orientale, DIFASS International S.p.a.
Abstract (Originalsprache)
Aim
To assess the efficacy of the combined administration of myo‐inositol and zinc, a mineral involved in the insulin pathway, in paediatric obesity with insulin resistance on HOMA‐IR, glucose‐insulin metabolism, and lipid profile. Materials and Methods Double‐blind, randomized, placebo‐controlled study conducted in North Italy. Fifty‐six patients (10–18 years, Tanner stage ≥3) with obesity and insulin resistance were randomized to myo‐inositol (2000 mg), zinc gluconate (5 mg), and galactooligosaccharides (GOS) from plant‐based origin (1000 mg) (TRT) or placebo (PLC) containing only GOS from plant‐based origin (1000 mg). All patients received an isocaloric diet following the Mediterranean diet style. Data were collected at baseline (V0) and after 3 months (V1). The primary outcome was the insulin resistance index (HOMA‐IR).
Results
Fifty out of 56 recruited subjects completed the study. TRT improved HDL cholesterol level compared to PLC ( p = 0.05) but not insulin resistance. A stratified post hoc analysis was performed by sex, BMI, and subgroups of adherence to the Mediterranean diet. Subjects were divided for obesity grade, fasting insulin ( p = 0.0137) and HOMA‐IR ( p = 0.0273) were lower in TRT than in PLC patients, with a greater effect on severe obesity. No adverse events were detected.
Conclusion
Three months of supplementation with myo‐inositol and zinc were beneficial on lipid profile and in managing obesity complications at least in subjects with severe phenotype. Thus, myo‐inositol and zinc could be used as non‐pharmacological agents. This work suggests a long‐term study with a larger sample size to enrich the findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
- Unit of Pediatrics Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
- Research and Development, DIFASS International S.p.a, Rimini, Italy.
- Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
- Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
ORCID-Profile: Ivana Rabbone, Flavia Prodam
Förderung
- Cariplo Foundation Grant
- University of Piemonte Orientale
- DIFASS International S.p.a
Zitieren
APA
Antoniotti, V., Partenope, C., Solito, A., Mancioppi, V., Baima, J., Medina, F., Dimarakis, S., Agostini, A., Sista, M. T., Monzani, A., Scotti, L., Rabbone, I., Prodam, F., & Bellone, S. (2025). Efficacy of myo‐inositol and zinc on insulin resistance in a paediatric population with obesity. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16185
Vancouver
Antoniotti V, Partenope C, Solito A, Mancioppi V, Baima J, Medina F, et al. Efficacy of myo‐inositol and zinc on insulin resistance in a paediatric population with obesity. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16185
BibTeX
@article{Antoniotti2025,
author = {Antoniotti, Valentina and Partenope, Cristina and Solito, Arianna and Mancioppi, Valentina and Baima, Jessica and Medina, Federico and Dimarakis, Sotirios and Agostini, Alida and Sista, Maria T and Monzani, Alice and Scotti, Lorenza and Rabbone, Ivana and Prodam, Flavia and Bellone, Simonetta},
title = {Efficacy of myo‐inositol and zinc on insulin resistance in a paediatric population with obesity},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.16185}
}
EUVIMED